We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Church & Dwight Co
CHD
$23.1B
| $3.23M | 0.02% |
67,376
+34,634
| +106% | +$1.71M |
|
|
MRSH
502
Marsh
MRSH
$86.3B
| $3.23M | 0.02% |
+48,015
| New | +$3.22M |
|
503
Sabre
SABR
$656M
| $3.21M | 0.02% |
113,906
-132,364
| -54% | -$3.69M |
|
504
CME Group
CME
$92.2B
| $3.17M | 0.02% |
30,342
-235,734
| -89% | -$24.6M |
|
|
EXPR
505
DELISTED
Express, Inc.
EXPR
| $3.14M | 0.02% |
13,316
+11,589
| +671% | +$3.14M |
|
506
Tenaris
TS
$29.1B
| $3.13M | 0.02% |
+110,042
| New | +$3.02M |
|
|
BRSS
507
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $3.1M | 0.02% |
+107,466
| New | +$3.05M |
|
508
Grand Canyon Education
LOPE
$3.71B
| $3.1M | 0.02% |
76,861
+33,677
| +78% | +$1.4M |
|
509
Aclaris Therapeutics
ACRS
$730M
| $3.09M | 0.02% |
+120,800
| New | +$2.56M |
|
510
Intuitive Surgical
ISRG
$121B
| $3.04M | 0.02% |
37,791
+10,422
| +38% | +$798K |
|
|
SCACU
511
DELISTED
Saban Capital Acquisition Corp. Units
SCACU
| $3.02M | 0.02% |
+300,000
| New | +$3.02M |
|
512
Huntsman Corp
HUN
$2.24B
| $3M | 0.02% |
184,091
+95,613
| +108% | +$1.51M |
|
|
TFCF
513
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $2.98M | 0.02% |
120,384
+28,565
| +31% | +$744K |
|
|
MYCC
514
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $2.96M | 0.02% |
+204,690
| New | +$2.99M |
|
|
ZAYO
515
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $2.93M | 0.02% |
98,726
+77,268
| +360% | +$2.23M |
|
516
Cenovus Energy
CVE
$54.6B
| $2.9M | 0.02% |
201,932
+191,698
| +1,873% | +$2.74M |
|
|
FRAN
517
DELISTED
Francesca's Holdings Corporation
FRAN
| $2.9M | 0.02% |
+15,653
| New | +$2.56M |
|
518
Theravance Biopharma
TBPH
$874M
| $2.87M | 0.02% |
79,068
+55,362
| +234% | +$1.54M |
|
519
MacroGenics
MGNX
$235M
| $2.86M | 0.02% |
95,716
-26,714
| -22% | -$795K |
|
|
EQM
520
DELISTED
EQM Midstream Partners, LP
EQM
| $2.86M | 0.02% |
37,488
+25,565
| +214% | +$1.99M |
|
521
Lantheus
LNTH
$6.82B
| $2.8M | 0.02% |
+338,381
| New | +$2.24M |
|
|
RMP
522
DELISTED
Rice Midstream Partners LP
RMP
| $2.8M | 0.02% |
+115,503
| New | +$2.43M |
|
523
DTE Energy
DTE
$31.1B
| $2.79M | 0.02% |
+34,993
| New | +$2.85M |
|
|
FMSA
524
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $2.79M | 0.02% |
+329,016
| New | +$2.44M |
|
|
RHT
525
DELISTED
Red Hat Inc
RHT
| $2.78M | 0.02% |
+34,383
| New | +$2.56M |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.